Clinical significance of cytogenetics and interphase fluorescence in situ hybridization analysis in newly diagnosed multiple myeloma in Taiwan
Authors:
- M. YaoMYM. Yao
- J.-L. TangJTJ.-L. Tang
- W. TsayWTW. Tsay
- F.-Y. LeeFLF.-Y. Lee
- M.-C. LiuMLM.-C. Liu
- C.-H. WangCWC.-H. Wang
- Y.-C. ChenYCY.-C. Chen
- M.-C. ShenMSM.-C. Shen
- H.-F. TienHTH.-F. Tien
Open Access
- 1 September 2005
- journal article
- research article
- Published by Elsevier in Annals of Oncology
- Vol. 16 (9) , 1530-1538
Abstract
Background: The incidence of multiple myeloma (MM) is lower in Asia than in Western countries. However, it is not known whether cytogenetic abnormalities (CA) characteristic of MM in Asia differ from those documented in the West. Patients and methods: We analyzed CA by conventional cytogenetics (CG) and/or fluorescence in situ hybridization (FISH), assessed their clinical significance in 150 Chinese MM patients and compared our data with that derived from Western countries. Results: CA were detected by CG (CG_CA) in 44 (29.3%) of the 150 patients and by FISH (FISH_CA) in 59 (67%) of the 88 patients studied. Presence of either CG_CA or FISH_CA was associated with a poor prognosis. Patients with CG_CA and hyperdiploid chromosomes, always associated with several trisomies, had a longer survival (median 25 months versus 12 months; P=0.025) in comparison with those with non-hyperdiploid chromosomes, usually associated with a monosomy 13/partial deletion of 13q (Δ13) and a rearrangement of 14q32. A novel recurrent CG_CA, add(19)(p13), was found in four patients: all males with immunoglobulin G/λ isotypes, extramedullary myeloma at diagnosis and a poor prognosis. Three groups of patients with significantly different survival, CG_Δ13, FISH_Δ13 but without CG_Δ13, and neither CG_Δ13 nor FISH_Δ13 (median 9 versus 15 versus 32 months; P=0.013) were identified. Conclusions: We conclude that MM CA in our patients are similar to those noted in Western countries, and that combined CG and FISH analysis can predict prognosis. The clinical significance of add(19)(p13) needs to be further investigated.Keywords
This publication has 38 references indexed in Scilit:
- Chromosomal abnormalities of 200 Chinese patients with non-Hodgkin's lymphoma in Taiwan: with special reference to T-cell lymphomaAnnals of Oncology, 2004
- Nonirradiated NOD/SCID-Human Chimeric Animal Model for Primary Human Multiple MyelomaThe American Journal of Pathology, 2004
- Treatment of multiple myelomaBlood, 2004
- t(11;14) and t(4;14) translocations correlated with mature lymphoplasmacytoid and immature morphology, respectively, in multiple myelomaLeukemia, 2003
- Additional chromosomal abnormalities and variability of BCR breakpoints in Philadelphia chromosome/BCR-ABL-positive acute lymphoblastic leukemia in TaiwanAmerican Journal of Hematology, 2002
- CRITERIA FOR EVALUATING DISEASE RESPONSE AND PROGRESSION IN PATIENTS WITH MULTIPLE MYELOMA TREATED BY HIGH‐DOSE THERAPY AND HAEMOPOIETIC STEM CELL TRANSPLANTATIONBritish Journal of Haematology, 1998
- Hypodiploidy and 22q11 rearrangements at diagnosis are associated with poor prognosis in patients with multiple myelomaBritish Journal of Haematology, 1997
- MULTIPLE MYELOMA: ALMOST ALL PATIENTS ARE CYTOGENETICALLY ABNORMALBritish Journal of Haematology, 1996
- Mapping basigin (BSG), a member of the immunoglobulin superfamily, to 19p13.3Cytogenetic and Genome Research, 1993
- Geographic heterogeneity of neoplasia‐associated chromosome aberrationsGenes, Chromosomes and Cancer, 1991